← Back to Search
CPPM 2013 Onward: Building A Socio-Technical GPS For Global Personalized Medicine - A Welcome To Editors-In-Chief Adrián LLerena (Spain) And Ross A. McKinnon (Australia)
V. Ozdemir, A. Llerena, R. McKinnon, S. Srivastava, E. Dove, L. Ferguson, M. Masellis, B. Nair, D. Gurwitz, L. Warnich
Published 2013 · Medicine
Download PDFAnalyze on Scholarcy
Pharmacogenomics, personalized medicine and global health are hot topics. They represent enormously active areas of research and development (R&D) and are situated at the epicenter of the genomics innovation and investment agenda, both in developed and resource-limited countries . The theme of “personalization” is taking on global significance in healthcare, not only in the case of drug therapy but also for other interventions such as vaccines and nutrition as well as targeted diagnostics and screening programs for early disease detection and preventive medicine. A fine example of the latter includes testing for deleterious mutations in
This paper references
Applying the genome to national drug formulary policy in the developing world.
M. Roederer (2010)
Mobile phone technologies and advanced data analysis towards the enhancement of diabetes self-management
I. Kouris (2010)
Asia-Pacific Health 2020 and Genomics without Borders: Co-Production of Knowledge by Science and Society Partnership for Global Personalized Medicine.
V. Ozdemir (2011)
Pharmacogenomics and Personalized Medicine for the Developing World - Too Soon or Just-in-Time? A Personal View from the World Health Organization
T. Pang (2009)
Personal genomics: information can be harmful
D. Ransohoff (2010)
Open User Innovation
E. Hippel (2010)
Crowd-funded micro-grants for genomics and "big data": an actionable idea connecting small (artisan) science, infrastructure science, and citizen philanthropy.
Vural Özdemir (2013)
Enterprising or altruistic selves? Making up research subjects in genetics research.
R. Tutton (2011)
Tackling the political determinants of global health
I. Kickbusch (2005)
Beyond the clinic: 'direct-to-consumer' genomic profiling services and pharmacogenomics.
B. Prainsack (2013)
Is there a need for PGxceptionalism?
M. Khoury (2011)
Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence
M. Khoury (2010)
Moving Toward Global Science
S. Suresh (2011)
The science of pharmacological variability: An essay
W. Kalow (1999)
Research funding: Global challenges need global solutions
S. Suresh (2012)
The ethical landscape: identifying the right way to think about the ethical and societal aspects of synthetic biology research and products
S. Yearley (2009)
A new look at the role of urinalysis in the history of diagnostic medicine.
W. White (1991)
Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).
V. Ozdemir (2011)
Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.
P. J. Reddy (2011)
Developing next-generation telehealth tools and technologies: patients, systems, and data perspectives.
M. Ackerman (2010)
Web-Based, Participant-Driven Studies Yield Novel Genetic Associations for Common Traits
N. Eriksson (2010)
Editorial (An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science)
Collet Dandara (2012)
Pharmacogenetics, pharmacogenomics, and pharmacobiology
W. Kalow (2001)
From Human Genetics and Genomics to Pharmacogenetics and Pharmacogenomics: Past Lessons, Future Directions
D. W. Nebert (2008)
Pharmacogenomics: questions and concerns
U. Mahlknecht (2005)
All the post-genomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health.
E. Dove (2013)
Enzymatic deficiency in primaquine-sensitive erythrocytes.
A. Alving (1956)
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.
V. Ozdemir (2012)
An Historical Perspective on the Clinical Diagnostic Laboratory
R. Moore (2006)
Health 2050: The Realization of Personalized Medicine through Crowdsourcing, the Quantified Self, and the Participatory Biocitizen
M. Swan (2012)
Adapting Standards: Ethical Oversight of Participant-Led Health Research
E. Vayena (2013)
Detienne Marcel, Les jardins d’Adonis. La mythologie des parfums et des aromates en Grèce et Les dieux d’Orphée
A. Motte (2007)